Medicine & Life Sciences
Sarcoma
100%
Gastrointestinal Stromal Tumors
78%
Doxorubicin
60%
Survival
29%
Neoplasms
29%
Denmark
26%
Leiomyosarcoma
25%
olaratumab
22%
gemcitabine
20%
TH 302
18%
sulofenur
17%
Therapeutics
17%
belinostat
16%
eribulin
15%
Trabectedin
14%
Drug Therapy
14%
Neck
14%
pazopanib
13%
Imatinib Mesylate
13%
Systematic Reviews
13%
Idarubicin
13%
Head
13%
Randomized Controlled Trials
13%
Circulating Tumor DNA
13%
Cardiotoxicity
13%
Merkel Cell Carcinoma
12%
Quality of Life
12%
Anthracyclines
12%
Phase III Clinical Trials
12%
Positron-Emission Tomography
12%
Recurrence
12%
Dacarbazine
11%
Paraganglioma
11%
Ifosfamide
11%
Tumor-Infiltrating Lymphocytes
11%
Hemangiosarcoma
11%
Sorafenib
11%
Phase II Clinical Trials
11%
Clinical Trials, Phase I
11%
Heart-Assist Devices
10%
Extracellular Vesicles
10%
Kaposi's Sarcoma
10%
Hyponatremia
10%
Regional Blood Flow
10%
Docetaxel
10%
Bone Diseases
10%
Pheochromocytoma
10%
Incidence
10%
Osteosarcoma
9%
Gray Matter
9%